Riga, 2014-12-10 09:03 CET (GLOBE NEWSWIRE) -- During the webinar Salvis Lapiņš said that considering current AS „Olainfarm” stock price tendencies, company’s Board has decided not to pursue the stock split idea, which was discussed earlier, for the time being.
Answering to the question of 2015 financial forecasts, Salvis Lapiņš noted that certain growth can be expected next year, but more detailed information is yet unknown.
The recorded “Olainfarm” webinar is available online: http://ej.uz/OLF_3Q_2014, and the presentation, demonstrated during the webinar, can be found in the previously published AS “Olainfarm” announcement: https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=636447&messageId=790219.
Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia
Information prepared by:
Salvis Lapins
Member of the Board
A/s „Olainfarm”
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv